Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant

NCT02297672 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT02297672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02297672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
Lead sponsor
British Columbia Cancer Agency
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 28, 2015
Completion date
February 28, 2026
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage breast cancer